HTFL Heartflow, Inc.
Heartflow, Inc. (HTFL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 13% planned / 87% discretionary
Largest single sale: $56.1M.
Where they traded
Last open-market purchase: December 16, 2025 , by Lightcap Jeffrey C .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 6,640 | $50.03 | $332.2K | 214,503 −3% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 27,540 | $49.69 | $1.4M | 221,143 −11.1% of holding | |
| Verghese Vikram | Chief Financial Officer | Sell 10b5-1 | 5,876 | $50.60 | $297.3K | 248,683 −2.3% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 27,230 | $50.00 | $1.4M | 360,814 −7% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 32,676 | $45.00 | $1.5M | 388,044 −7.8% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 9,219 | $41.23 | $380.1K | 86,459 −9.6% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 15,560 | $39.06 | $607.8K | 420,720 −3.6% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $28.31 | $638.7K | 436,280 −4.9% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 9,219 | $25.72 | $237.1K | 88,731 −9.4% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $27.75 | $626.1K | 435,373 −4.9% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 38,900 | $35.00 | $1.4M | 457,935 −7.8% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $28.50 | $643.0K | 496,835 −4.3% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 9,219 | $28.34 | $261.3K | 78,731 −10.5% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $29.12 | $657.0K | 519,397 −4.2% of holding | |
| 2 fills | Sell | 948,757 | $29.23 | $27.7M | 8,504,382 −10% of holding | ||
| Sell | 797,133 | $29.37 | $23.4M | 9,396,915 −7.8% of holding | |||
| Sell | 254,110 | $30.51 | $7.8M | 10,194,048 −2.4% of holding | |||
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $26.72 | $602.9K | 549,163 −3.9% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 64,533 | $24.64 | $1.6M | 81,002 −44.3% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 64,533 | $25.69 | $1.7M | 78,518 −45.1% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 9,725 | $25.00 | $243.1K | 571,725 −1.7% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 12,837 | $22.66 | $290.9K | 581,450 −2.2% of holding | |
| Cullivan Julie A | Director | Sell 10b5-1 | 9,122 | $25.00 | $228.1K | 27,291 −25.1% of holding | |
| Rogers Campbell | Chief Medical Officer | Sell 10b5-1 | 65,153 | $24.49 | $1.6M | 76,034 −46.1% of holding | |
| Farquhar John C.M. | Chief Executive Officer | Sell 10b5-1 | 22,562 | $27.46 | $619.6K | 591,656 −3.7% of holding | |
| Cullivan Julie A | Director | Sell 10b5-1 | 8,000 | $27.32 | $218.6K | 36,413 −18% of holding | |
| Sell | 2,000,000 | $28.05 | $56.1M | 10,448,158 −16.1% of holding | |||
| Lightcap Jeffrey C | Director | Buy | 40,000 | $26.34 | $1.1M | 40,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.